Dexter Susan - Insider Non-Derivative Transactions at Sonnet BioTherapeutics Holdings, Inc. (SONN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 14, 2023, Dexter Susan's relationship to Sonnet BioTherapeutics Holdings, Inc. (SONN) is Officer (Chief Technical Officer), and currently has 33,667 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SONN insiders.

Data Source: SEC.
Dexter Susan - Insider Non-Derivative Transactions of SONN Common Stock
Dexter Susan - Insider Non-Derivative Transactions at SONN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 15, 2023 P -- (Common Stock) 10000 0.7 33667
Jan 8, 2023 Disposition -- (Common Stock) 14627 0 9040
Jan 8, 2023 Acquisition -- (Common Stock) 14627 0 23667